Vaccine Development Solutions
Advanced end-to-end solutions underpinning the development of vaccines to combat infectious diseases
Unrivalled Expertise in Vaccine Development
Synexa Life Sciences offers a comprehensive array of solutions designed to assess the efficacy and immunogenicity of vaccine candidates. Our vaccine services are meticulously designed to investigate both cellular and humoral immune responses, providing a holistic view of vaccine efficacy.
Utilising advanced techniques such as flow cytometry, MHC multimer analysis, and cutting-edge immunoassays, we enable customers to delve deeply into the immune responses elicited by vaccines. Through rigorous evaluations, we empower customers with the critical data needed to make informed decisions, facilitating the development of vaccines that are both safe and effective.
Our Vaccine Services
Flow Cytometry
An extensive portfolio of phenotypic and functional flow cytometry assays to assess response against vaccine antigens. Assays can be combined with tetramer/pentamer analysis for HLA specific T-cell subsets.
ELISpot
As a top performing member of the Immudex ELISpot Proficiency Panel, we provide single or dual-color ELISpot immunostaining in response to a portfolio of vaccine antigens.
Humoral Response Analysis
Singleplex or multiplex vaccine immunogenicity assays by ELISA, MSD, Alphalisa, Gyros and DELFIA across a range of matrices including serum, plasma, dry blood spot, saliva and stool.
Laboratory Solutions for Vaccine Clinical Trials
Learn more about our vaccine services and expertise.
A Complete End-to-End Lab Solution for Vaccine Development
Synexa has partnered with Cytespace Laboratories Africa to provide a complete end-to-end solution for vaccine development. Our combined expertise offers a comprehensive service, from central lab and safety marker analysis to intricate biomarker and bioanalysis, ensuring samples are prepared and processed to their fullest potential.
Improving the quality of human health
Contact us
Discuss biomarker and bioanalytical solutions to accelerate your therapeutic pipeline
